Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» COVID-19
COVID-19
Pfizer’s full-year revenues grow 23%, top $100B
Pfizer’s full-year revenues grow 23%, top $100B
Medical Marketing and Media
Pfizer
earnings
COVID-19
Paxlovid
vaccines
Flag link:
FDA to resume in-person formal meetings in February
FDA to resume in-person formal meetings in February
RAPS.org
FDA
regulatory
pandemic
COVID-19
Flag link:
Pharma reputation drops to pre-pandemic normal, with Pfizer and Moderna falling in the ranks
Pharma reputation drops to pre-pandemic normal, with Pfizer and Moderna falling in the ranks
Medical Marketing and Media
reputation
pandemic
COVID-19
Pfizer
Moderna Therapeutics
Flag link:
WHO extends public health emergency over Covid but signals end could come soon
WHO extends public health emergency over Covid but signals end could come soon
Stat
WHO
COVID-19
Public Health
Flag link:
After 'half-baked' data drop, CureVac releases results on mRNA flu, COVID-19 vaccines in older adults
After 'half-baked' data drop, CureVac releases results on mRNA flu, COVID-19 vaccines in older adults
Fierce Biotech
CureVac
clinical trials
MRNA
vaccines
COVID-19
Flu
GSK
Flag link:
Following FDA COVID vaccine advisory panel vote, Novavax is prepared to provide a revised vaccine
Following FDA COVID vaccine advisory panel vote, Novavax is prepared to provide a revised vaccine
CP WIre
Novavax
FDA
vaccines
COVID-19
boosters
Flag link:
Following FDA COVID vaccine advisory panel vote, Novavax is prepared to provide a revised vaccine
Novavax
FDA
vaccines
COVID-19
boosters
Flag link:
FDA reports initial 'no signal' for stroke risk with Pfizer boosters, launches concomitant flu shot study
FDA reports initial 'no signal' for stroke risk with Pfizer boosters, launches concomitant flu shot study
Endpoints
Pfizer
bivalent boosters
vaccines
COVID-19
stroke
Flag link:
FDA advisers back agency plan to simplify COVID-19 vaccination
FDA advisers back agency plan to simplify COVID-19 vaccination
BioPharma Dive
FDA
COVID-19
vaccines
Flag link:
FDA yanks EUA for AstraZeneca’s Evusheld as COVID variants continue to evolve
FDA yanks EUA for AstraZeneca’s Evusheld as COVID variants continue to evolve
Medical Marketing and Media
AstraZenenca
FDA
Evusheld
COVID-19
Emergency Use Authorization
Flag link:
BMS settles lawsuit with two fired employees who refused COVID vaccines
BMS settles lawsuit with two fired employees who refused COVID vaccines
Fierce Pharma
Bristol Myers Squibb
legal
COVID-19
vaccines
Flag link:
Two new studies paint encouraging picture of Covid-19 vaccine’s performance
Two new studies paint encouraging picture of Covid-19 vaccine’s performance
Stat
COVID-19
vaccines
boosters
Flag link:
Moderna now in the crosshairs of Sens. Warren, Welch over price tag for COVID vaccine
Moderna now in the crosshairs of Sens. Warren, Welch over price tag for COVID vaccine
Fierce Pharma
Moderna Therapeutics
drug pricing
vaccines
COVID-19
Senate
Flag link:
Abbott Laboratories Skids As Covid Testing Weighs On Organic Growth
Abbott Laboratories Skids As Covid Testing Weighs On Organic Growth
Investors Business Daily
Abbott Labs
earnings
diagnostics
COVID-19
Flag link:
3 Reasons Why Johnson & Johnson Stock Could Rebound After a Bad Start in 2023
3 Reasons Why Johnson & Johnson Stock Could Rebound After a Bad Start in 2023
Motley Fool
JNJ
COVID-19
consumer health
foreign exchange rates
Flag link:
Dyadic initiates subject dosing in Phase I trial of Covid-19 booster
Dyadic initiates subject dosing in Phase I trial of Covid-19 booster
Clinical Trials Arena
clinical trials
Dyadic
COVID-19
vaccines
DYAI-100
Flag link:
Axcella Clears Regulatory Path for Long COVID Therapeutic
Axcella Clears Regulatory Path for Long COVID Therapeutic
BioSpace
Axcella Therapeutics
Long COVID
COVID-19
AXA1125
UK
Flag link:
Tevogen Bio reports positive data from Covid-19 T cell therapy trial
Tevogen Bio reports positive data from Covid-19 T cell therapy trial
Clinical Trials Arena
Tevogen Bio
clinical trials
cell therapy
TVGN 489
COVID-19
Flag link:
mRNA Covid Shots Safe And Effective In Children Ages 5-11, Large Study Finds—Though Vaccine Uptake Remains Low
mRNA Covid Shots Safe And Effective In Children Ages 5-11, Large Study Finds—Though Vaccine Uptake Remains Low
Forbes
Pfizer
Moderna Therapeutics
vaccines
COVID-19
pediatrics
MRNA
Flag link:
FDA considers major shift in COVID vaccine strategy
FDA considers major shift in COVID vaccine strategy
NPR
FDA
COVID-19
vaccines
boosters
Flag link:
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »